RYE BROOK, N.Y., July 12, 2017 /PRNewswire/ -- IndexIQ, a leading provider of innovative investment solutions, today announced that it is lowering the total expense ratio (TER) for its suite of 50 percent currency hedged international equity ETFs, as of July 12, 2017.
The names and tickers of the funds having their fees reduced (after fee waiver and expense limitation) are as follows:
"We're pleased to make it more cost-efficient for investors to access the benefits of our 50 percent hedged suite of international equity ETFs," said IndexIQ's Chief Investment Officer Salvatore Bruno.
"HFXI and the other funds in this product suite have performed exactly as designed since we launched them in July of 2015, even as Brexit, the results of the U.S. election, and a push for a weaker dollar have whipsawed the currency market in different and frequently counterintuitive ways," added Bruno. "With these lower fees, this innovative family of funds is even better positioned for future growth."
About IndexIQ
IndexIQ is a pioneer and leading provider of innovative investment solutions focused on absolute return, real assets, international and fixed income strategies. IndexIQ's solutions are offered as ETFs, mutual funds, separately managed accounts, and ETF model portfolios. The company's philosophy is to democratize investment management by providing all investors with cost-effective access to the types of high-quality, sophisticated investment products that typically have been reserved for institutional and ultra high-net-worth investors. IndexIQ's mission is to take indexing to the next level by combining the best attributes of both passive and active investing, and make strategies available to investors in low cost, liquid, and transparent products**. IndexIQ is an indirect, wholly-owned subsidiary of New York Life Insurance Company. Additional information about IndexIQ and its products can be found at IQetfs.com.
For additional information, please contact: |
|
Chris Sullivan/Mike MacMillan |
Allison Scott |
MacMillan Communications |
New York Life Insurance |
(212) 473-4442 |
(212) 576-4517 |
Consider the Fund's investment objectives, risks, and charges and expenses carefully before investing. The prospectus and the statement of additional information include this and other relevant information about the Fund and are available by visiting IQetfs.com or calling 888-934-0777. Read the prospectus carefully before investing.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called "creation units", and otherwise, can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in-kind.
1 IndexIQ has contractually agreed, until August 31, 2018, to waive or reduce its management fee and/or reimburse expenses of the Fund in an amount that limits the operating expenses of the Fund (exclusive of interest, taxes, brokerage fees and commissions, dividends paid on short sales, acquired fund fees and expenses, and extraordinary expenses) to not more than 0.20% of the average daily net assets of the Fund.
2 IndexIQ has contractually agreed, until August 31, 2018, to waive or reduce its management fee and/or reimburse expenses of each Fund in an amount that limits the operating expenses of the Fund (exclusive of interest, taxes, brokerage fees and commissions, dividends paid on short sales, acquired fund fees and expenses, and extraordinary expenses) to not more than 0.30% of the average daily net assets of the Fund.
3 IndexIQ has contractually agreed, until August 31, 2018, to waive or reduce its management fee and/or reimburse expenses of each Fund in an amount that limits the operating expenses of the Fund (exclusive of interest, taxes, brokerage fees and commissions, dividends paid on short sales, acquired fund fees and expenses, and extraordinary expenses) to not more than 0.30% of the average daily net assets of the Fund.
SOURCE IndexIQ
Share this article